The First 100 Days of an Ashley Moody Presidency: What the Record Suggests

Hero photo: Aerial view of the Florida Capitol, 1948 — via Wikimedia Commons.

01 The scenario

Ashley Moody of Florida is a first-term Republican senator, appointed on January 21, 2025 by Governor Ron DeSantis to fill the seat vacated by Marco Rubio and sworn in the same day. Before that she was Florida's 38th Attorney General (2019-2025), and before that a prosecutor and a circuit court judge in Hillsborough County. This article asks a hypothetical question: if she were ever sworn in as president, what would the first 100 days look like based on her documented record? This is a scenario analysis, not a prediction that the person will become president and not an endorsement or criticism of the person.

Moody's record is a law-enforcement record transported into federal office: her agenda is the fentanyl fight, federal-state enforcement partnership, and loyalty to the party's deregulatory and healthcare positions. A reasonable inference from these positions is that a Moody White House would open with the levers a president holds alone — DOJ and FDA scheduling directives, CBP and DEA interdiction surges, HHS opioid grant steering, EPA regulatory direction — while the HALT Fentanyl Act's permanent scheduling changes and the Servicemember Residence Protection Act would require congressional approval rather than unilateral presidential action.

02 The record: who Ashley Moody is

Moody is a fifth-generation Floridian who served as the state's 38th Attorney General from 2019 to 2025 before her Senate appointment. Her official site carries the slogan “Serving the Great Free State of Florida.” In the Senate she sits on Appropriations; Homeland Security and Governmental Affairs; Indian Affairs; the Special Committee on Aging; and the Joint Economic Committee — and on March 26, 2026 she joined the Senate Armed Services Committee, per her press release and Chairman Wicker's announcement.

The committee map matters for the scenario: Appropriations gives her spending leverage; Homeland Security and Governmental Affairs gives her the DHS-oversight lane that matches her law-enforcement record; Armed Services adds defense jurisdiction in year two of her tenure. Votes with the Republican party line roughly 98.35 percent of the time per the nowyouknow.vote scorecard.

03 Fentanyl and the opioid crisis

The opioid crisis is Moody's central issue as both attorney general and senator. She cosponsored the HALT Fentanyl Act (S. 331, 119th Congress), announced March 7, 2025 per her Senate office release. An April 7, 2026 release highlights Senate-passed cosponsored legislation to help medical professionals detect opioid misuse. A May 19, 2026 release cites a 46 percent drop in Florida fentanyl-related deaths and pushes legislation “to keep nation moving in the right direction.” On August 21, 2026, National Fentanyl Prevention and Awareness Day, she issued a statement renewing her commitment to end the opioid crisis.

The lever split: the interdiction and enforcement pieces — CBP and DEA surges, DOJ and FDA scheduling directives, HHS grant steering — are executive levers a president already controls. The HALT Fentanyl Act's permanent scheduling changes require Congress. This would require congressional approval rather than unilateral presidential action, which is precisely why she filed the bill as a senator rather than asking an administration to act alone.

04 Law, order, and federal-state enforcement

In a Homeland Security Committee statement titled “Strong National & State Leadership is Necessary to Maintain Law & Order,” Moody argued for a stronger federal-state partnership on enforcement, per her Senate site. That is the position of a former state attorney general who spent six years running Florida's top law-enforcement office.

A reasonable inference from these positions is that a Moody administration would direct DOJ and DHS toward cooperative-enforcement frameworks with states. Evidence strength on the specific mechanisms: moderate — the statement is directional advocacy, not a drafted bill, so the concrete policy instruments are not documented. As a HSGAC member she would in any case exercise oversight of any administration's DHS enforcement, including her own.

05 Environmental deregulation

Moody joined President Trump and EPA Administrator Lee Zeldin in the Oval Office as Trump announced a rollback of harsher emissions rules, per capitol releases of her press statement in May 2026. She appeared with Trump in The Villages on May 1, 2026 to tout “Florida blueprint” policy wins.

Emissions-rule rollback is squarely an EPA regulatory action a president can direct on day one — among the cleanest unilateral levers in Moody's documented record. The contrast with her opioid agenda is the interesting part: on fentanyl she needs statutes, on emissions she would not, because the deregulatory instrument is agency rulemaking under existing law.

06 Healthcare and the ACA subsidy vote

On December 11, 2025, Moody voted NO on the cloture motion for S. 3385, which would have extended enhanced ACA subsidies for three years. Cloture was rejected 51-48 (Roll Call 644). Both the Freedom Index and the AFL-CIO scorecard record her vote against what those trackers label the “Lower Health Care Costs Act.”

Beyond that roll call, her documented healthcare record in this pass is thin: the opioid-detection legislation of April 2026 is the other visible item. There is not enough public evidence to determine a broader Moody healthcare agenda — the vote documents opposition to the subsidy extension, not a substitute program. Subsidy law itself is statutory, so any first-100-days move on it would run through Congress.

07 Veterans

Moody sponsored S. 4910, the Servicemember Residence Protection Act of 2026, introduced June 24, 2026 and referred to the Veterans' Affairs Committee. On September 18, 2026 she honored a former prisoner of war with a National POW/MIA Recognition Day congressional resolution.

The residence-protection bill would require congressional approval rather than unilateral presidential action — but much of a veterans agenda runs through executive direction of the VA, and her Armed Services Committee seat, added March 26, 2026, gives her the jurisdiction to match.

08 What the record cannot tell us

The evidence runs out in specific places. There is not enough public evidence to determine Moody's positions on tariffs, trade, or taxes — no independently documented position was found beyond general “America First” campaign-site language, and her campaign site is promotional rather than a policy source of record. Her sponsored-bill counts conflict across trackers (37 versus 49 bills in the 119th Congress); the exact total is unverified. Her office was recognized for “Best Constituent Services in the Senate” in 2026 per her own site headline, but the awarding body is not independently verified. No verified public statement from Moody on the 2026 Iran war was found in this pass. Ballotpedia returned an HTTP error during the underlying research, so the committee list rests on GovTrack, LegiList, govinfo, and her own releases instead.

Disclaimer: this article is a scenario analysis based on the documented public record as of September 21, 2026. It is not a prediction that Ashley Moody will become president, nor an endorsement or criticism of her or her positions. Where evidence is incomplete, that is stated rather than filled in.